HomeAI · summaries
Storia in 3 fonti
Dr Reddy's flags quality issue in semaglutide batches, delays commercial supplies
Dr Reddy's Laboratories has announced a setback in the distribution of their semaglutide products attributed to out-of-specification batches associated with an active ingredient concern. The firm is actively investigating to identify the source of the problem and is implementing corrective strategies.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Dr Reddy's flags quality issue in semaglutide batches, delays commercial supplies
Dr Reddy's Laboratories has announced a setback in the distribution of their semaglutide products attributed to out-of-specification batches associated with an active ingredient…
- ·
thehindubusinessline.com
Dr Reddy's delays semaglutide supply due to active ingredient issue
Dr. Reddy's delays semaglutide supply due to ingredient issues, impacting shares but posing no safety risks.
- ·
thehindu.com
Dr. Reddy’s to delay semaglutide supplies due to quality isssue, shares hit
Dr. Reddy’s delays semaglutide supplies over quality issues, causing shares to drop amid ongoing investigations and commitment to product safety.
- ·
Dr. Reddy’s to delay semaglutide supplies due to quality issue, shares hit
Dr. Reddy’s delays semaglutide supplies over quality issues, causing shares to drop amid ongoing investigations and commitment to product safety.
- ·
Dr Reddy's shares slide 7% after delay in semaglutide supplies over quality concerns
Dr Reddy's shares fell sharply on Thursday after the company delayed commercial supplies of its semaglutide product due to a quality issue involving the active pharmaceutical…
- ·
Dr Reddy's delays Semaglutide supplies after API-related quality issue
Dr Reddy's delayed Semaglutide supplies after certain batches failed quality specifications due to an API issue. The company said patient safety is unaffected.
- ·
DRL’s semaglutide supply hits a stumbling block, affects other companies too
Generic supplies of semaglutide from Dr Reddy’s Laboratories have hit a stumbling block, and this is having a domino effect across other companies, including Torrent…
- ·
Dr. Reddy’s halts semaglutide supplies on quality concerns, shares plunge, Torrent recalls product
No impact on patient safety or on the product’s existing global regulatory filings
- ·
Dr Reddy’s pauses weight loss drug on quality fears
Dr Reddy's Laboratories will halt semaglutide injection supplies until at least October. Unspecified impurities were identified during the active pharmaceutical ingredient…